Astria Reports Positive Phase 1a Data for STAR-0310, a Long-Acting OX40 Antagonist

Retrieved on: 2025-09-20 19:56:15

Tags for this article:

Click the tags to see associated articles and topics

Astria Reports Positive Phase 1a Data for STAR-0310, a Long-Acting OX40 Antagonist. View article details on hiswai:

Excerpt

Evidence presented at EADV supports upadacitinib's long-term use in atopic dermatitis and other inflammatory conditions. ... extended treatment duration ...

Article found on: www.dermatologytimes.com

View Original Article